LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care.
With most of its products indicated for serious and rare diseases, LFB is a major player in this area.
The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies.
With a sustained investment in research and development, the LFB Group bases its strategy on its international deployment and the design of innovative therapies.
medicaments derives du plasma, medicaments issus du vivant, bioproduction
Outlook, MailJet, Workday Recruit, Nginx, Piwik, WordPress.org, Mobile Friendly